An enzyme called CEMIP could be a target for small-molecule inhibitors that aim to promote myelin repair in people with multiple sclerosis (MS) and other conditions marked by myelin loss, a study found. Researchers discovered that CEMIP, which is elevated in areas of inflammatory nerve damage in people with MS, produces numerous hyaluronic acid molecules […]
The post Researchers identify enzyme as new target for MS myelin repair appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com